• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Brief History of Biomedical Research Ethics in Iran: Conflict of Paradigms.伊朗生物医学研究伦理简史:范式冲突
Dev World Bioeth. 2015 Aug;15(2):107-12. doi: 10.1111/dewb.12053. Epub 2014 Apr 11.
2
Contemporary medical ethics: an overview from Iran.当代医学伦理学:来自伊朗的概述。
Dev World Bioeth. 2008 Dec;8(3):192-6. doi: 10.1111/j.1471-8847.2006.00180.x.
3
A theory of international bioethics: multiculturalism, postmodernism, and the bankruptcy of fundamentalism.一种国际生物伦理学理论:多元文化主义、后现代主义与原教旨主义的破产
Kennedy Inst Ethics J. 1998 Sep;8(3):201-31. doi: 10.1353/ken.1998.0017.
4
A defense of fundamental principles and human rights: a reply to Robert Baker.对基本原则和人权的辩护:对罗伯特·贝克的回应
Kennedy Inst Ethics J. 1998 Dec;8(4):403-22. doi: 10.1353/ken.1998.0031.
5
Clinical research 2: legal and ethical issues in research.临床研究2:研究中的法律与伦理问题。
Intensive Crit Care Nurs. 2004 Oct;20(5):313-5. doi: 10.1016/j.iccn.2004.04.006.
6
Empty ethics: the problem with informed consent.空洞的伦理:知情同意的问题
Sociol Health Illn. 2003 Nov;25(7):768-92. doi: 10.1046/j.1467-9566.2003.00369.x.
7
Bioethics in Mediterranean culture: the Spanish experience.地中海文化中的生物伦理学:西班牙的经验。
Med Health Care Philos. 2012 Nov;15(4):437-51. doi: 10.1007/s11019-011-9354-8.
8
Limits of autonomy in biomedical ethics?: conceptual clarifications.生物医学伦理学中的自主性限度?:概念阐释
Camb Q Healthc Ethics. 2011 Oct;20(4):524-32. doi: 10.1017/S0963180111000260.
9
Autonomy, beneficence, and the experimental subject's consent: a response to Jay Katz.自主性、善行与实验对象的同意:对杰伊·卡茨的回应
St Louis Univ Law J. 1993 Fall;38(1):55-62.
10
Patient access to experimental drugs and AIDS clinical trial designs: ethical issues.患者获取实验性药物与艾滋病临床试验设计:伦理问题
Camb Q Healthc Ethics. 1996 Summer;5(3):400-9. doi: 10.1017/s0963180100007209.

引用本文的文献

1
Factors Influencing Paternalistic Clinical Environment in Iran: An Exploratory Research Brief.影响伊朗家长式临床环境的因素:一项探索性研究简报。
J Patient Exp. 2025 May 30;12:23743735251346665. doi: 10.1177/23743735251346665. eCollection 2025.
2
Assessment of biobank awareness among medical students in Iran.伊朗医学生对生物样本库的认知评估。
J Community Genet. 2025 Apr;16(2):183-193. doi: 10.1007/s12687-025-00769-4. Epub 2025 Jan 21.
3
Skin Rejuvenation with Cultured Melanocyte and Fibroblasts in a Medical Tourism Patient.一名医疗旅游患者采用培养的黑素细胞和成纤维细胞进行皮肤年轻化治疗。
World J Plast Surg. 2022;11(3):116-121. doi: 10.52547/wjps.11.3.116.
4
Sharing, reuse, and storage of biosamples among biomedical researchers in Jordan: Practice and concerns.约旦生物医学研究人员之间的生物样本共享、再利用和存储:实践和关注点。
PLoS One. 2022 Apr 28;17(4):e0267552. doi: 10.1371/journal.pone.0267552. eCollection 2022.
5
Evolution of Iran's health research system over the past 50 years: a narrative review.伊朗卫生研究系统在过去 50 年中的发展历程:叙事性回顾。
J Glob Health. 2018 Dec;8(2):020703. doi: 10.7189/jogh.08.020703.
6
Continuing review of ethics in clinical trials: a surveillance study in Iran.对临床试验伦理的持续审查:伊朗的一项监测研究
J Med Ethics Hist Med. 2014 Dec 28;7:22. eCollection 2014.

本文引用的文献

1
A bibliometric overview of 30 years of medical sciences productivity in iran.伊朗医学科学 30 年生产力的文献计量概述。
Arch Iran Med. 2010 Jul;13(4):313-7.
2
Contemporary medical ethics: an overview from Iran.当代医学伦理学:来自伊朗的概述。
Dev World Bioeth. 2008 Dec;8(3):192-6. doi: 10.1111/j.1471-8847.2006.00180.x.
3
The influences of bioethics and Islamic jurisprudence on policy-making in Iran.生物伦理学与伊斯兰法学对伊朗政策制定的影响。
Am J Bioeth. 2007 Oct;7(10):42-4. doi: 10.1080/15265160701588196.
4
An Islamic view to stem cell research and cloning: Iran's experience.关于干细胞研究与克隆的伊斯兰视角:伊朗的经验
Am J Bioeth. 2007 Feb;7(2):62-3. doi: 10.1080/15265160601109697.
5
Emerging concerns about Iran's scientific and medical future.对伊朗科学和医学未来的新担忧。
Lancet. 2006 Sep 16;368(9540):985. doi: 10.1016/S0140-6736(06)69403-8.
6
Strengthening medical ethics by strategic planning in the Islamic Republic of Iran.通过战略规划加强伊朗伊斯兰共和国的医学伦理。
Dev World Bioeth. 2006 May;6(2):106-10. doi: 10.1111/j.1471-8847.2006.00145.x.
7
Ethics and clinical research.伦理与临床研究
N Engl J Med. 1966 Jun 16;274(24):1354-60. doi: 10.1056/NEJM196606162742405.

伊朗生物医学研究伦理简史:范式冲突

A Brief History of Biomedical Research Ethics in Iran: Conflict of Paradigms.

作者信息

Aramesh Kiarash

出版信息

Dev World Bioeth. 2015 Aug;15(2):107-12. doi: 10.1111/dewb.12053. Epub 2014 Apr 11.

DOI:10.1111/dewb.12053
PMID:24720443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4194183/
Abstract

During the past two decades, Iran has experienced a noteworthy growth in its biomedical research sector. At the same time, ethical concerns and debates resulting from this burgeoning enterprise has led to increasing attention paid to biomedical ethics. In Iran, Biomedical research ethics and research oversight passed through major periods during the past decades, separated by a paradigm shift. Period 1, starting from the early 1970s, is characterized by research paternalism and complete reliance on researchers as virtuous and caring physicians. This approach was in concordance with the paternalistic clinical practice of physicians outside of research settings during the same period. Period 2, starting from the late 1990s, was partly due to revealing of ethical flaws that occurred in biomedical research in Iran. The regulatory and funding bodies concluded that it was not sufficient to rely solely on the personal and professional virtues of researchers to safeguard human subjects' rights and welfare. The necessity for independent oversight, emphasized by international declarations, became obvious and undeniable. This paradigm shift led to the establishment of research ethics committees throughout the country, the establishment of academic research centers focusing on medical ethics (MEHR) and the compilation of the first set of national ethical guidelines on biomedical research-one of the first and most important projects conducted by and in the MEHR. Although not yet arrived, 'period 3' is on its way. It is predictable from the obvious trends toward performance of high-quality clinical research and the appearance of a highly educated new generation, especially among women.

摘要

在过去二十年中,伊朗的生物医学研究领域取得了显著发展。与此同时,这一蓬勃发展的事业引发的伦理问题和争论,使得生物医学伦理受到了越来越多的关注。在伊朗,生物医学研究伦理与研究监督在过去几十年经历了主要阶段,各阶段之间存在范式转变。第一阶段始于20世纪70年代初,其特点是研究家长主义以及完全依赖研究人员,将其视为品德高尚且关怀备至的医生。这种方法与同一时期研究环境之外医生的家长式临床实践相一致。第二阶段始于20世纪90年代末,部分原因是伊朗生物医学研究中出现的伦理缺陷被揭露。监管和资助机构得出结论,仅依靠研究人员的个人和职业品德来保护人类受试者的权利和福利是不够的。国际宣言所强调的独立监督的必要性变得明显且不可否认。这种范式转变导致在全国范围内设立了研究伦理委员会,建立了专注于医学伦理的学术研究中心(MEHR),并编纂了第一套生物医学研究国家伦理准则——这是MEHR开展并参与的首批也是最重要的项目之一。尽管“第三阶段”尚未到来,但已在路上。从高质量临床研究的明显趋势以及新一代,尤其是女性中高学历群体的出现可以预测到这一点。